HOME >> BIOLOGY >> NEWS
Hope available for patients with anemia and myelodysplastic syndrome

(San Diego, Calif., December 8, 2003) Several studies presented during the 45th Annual Meeting of the American Society of Hematology (ASH) provide hope for patients with red blood cell diseases in the form of potential new treatments, as well as guidance for health care providers in caring for patients.

Anemia is a disease in which the blood lacks adequate healthy red blood cells to carry appropriate levels of oxygen to patients' tissues, making them feel tired. Many types of anemia exist, each with its own cause, such as an iron or vitamin deficiency, blood loss, chronic illness, a genetic or acquired defect or disease, or a medication side effect. Anemia can be temporary or long-term and can range from mild to severe. Anemia affects more than three million Americans, making it the most common blood disorder in the United States. Women and people with chronic diseases are at increased risk for the condition.

A related disease is myelodysplastic syndrome, a disease that in mild cases may present primarily as anemia. Myelodysplastic syndrome (MDS) is characterized by abnormal blood-forming cells of the bone marrow, which produce too few red blood cells, white blood cells, and platelets. The bone marrow is unable to produce blood cells effectively, and many of the formed cells are abnormal or defective. The abnormal cells are usually destroyed before they leave the bone marrow or shortly after they enter the bloodstream. As a result, patients experience a shortage of blood cells, which is reflected in their low blood counts. MDS may be a form of cancer, according to most hematologists, since it is considered a clonal disease with a single population of abnormal cells.

"These blood disorders are not simply quality of life diseases, but carry with them serious health concerns that may endanger patients' lives," said Stanley Schrier, M.D., President-Elect of the American Society of Hem
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Society of Hematology
8-Dec-2003


Page: 1 2 3 4 5 6

Related biology news :

1. National Corn Growers Association announces valuable maize genome data now available to scientists
2. New human embryonic stem-cell lines to be made available to researchers
3. Should publicly funded research be free and available to the public?
4. Laser technology to map industrial plant gases available through Alberta Research Council
5. Why results from genetic tests should be available to medical insurance companies
6. Research grants available for faculty at minority serving institutions
7. Physician experts available to speak on California fires and smoke inhalation
8. Seven CD-ROM global GIS data set available from AGI
9. QuikClot (TM) will be made available to public
10. 2 Million of yeast to triple available drug treatments
11. K-State professor studies medications available for llamas, alpacas

Post Your Comments:
(Date:5/21/2013)... scientists have developed many devices that can reopen clogged ... effective, each of these treatments has drawbacks, including the ... MIT analyzes the potential usefulness of a new treatment ... stents, but may pose fewer risks. With this new ... only a brief period, during which it releases a ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
(Date:5/20/2013)... University of Minnesota Medical School researchers from the ... the University,s Brain Tumor Program, have developed a new ... that allow them to discover new genes and gene ... was published this week in the journal Nature ... researchers in the lab of David Largaespada, Ph.D., professor ...
Breaking Biology News(10 mins):Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2U of M researchers develop model for better testing, targeting of MPNST 2
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013  Moderna ... revolutionary new treatment modality to enable the in ... John Reynders will join Moderna ... Reynders is a proven leader in ... phases of drug development, from discovery to translation, clinical ...
(Date:5/21/2013)... YORK , May 21, 2013  The Lindsley F. ... today that it is a Grand Challenges Explorations ... Gates Foundation .  Dr. Sara Lustigman , ... innovative global health and development research project, titled Innovative ...  These worms are needed to screen drugs to help ...
(Date:5/21/2013)... by George Washington University Professor Tianshu Li provide ... small droplets is strongly size-dependent, an important conclusion ... formation of ice at the nanoscale is a ... has important implications for climate research and other ... supercooled water is generally initiated by a process ...
(Date:5/21/2013)... NJ (PRWEB) May 21, 2013 Savoury ... industry, has appointed Dale Braddy to Southeastern USA Sales ... bolster its sales muscle in the Southeast. ... food ingredient brokerage and supplier to food processors and ... 13 years in the food industry and has over ...
Breaking Biology Technology:Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2
Cached News: